{"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"groups":[{"description":"Radiation Therapy on weeks 1, 3, 5, and 7 1.5 Gy/fx, twice daily x 5 days, 40 fractions, for a total dose of 60 Gy Chemotherapy (cisplatin/paclitaxel) on weeks 1, 3, 5, and 7 G-CSF on weeks 2, 4, 6, and 8","id":"OG000","title":"Re-irradiation Plus Concurrent Chemotherapy"},{"description":"Select from one of the three standard chemotherapy regimens:\n\ncisplatin/5-FU; cisplatin/paclitaxel; cisplatin/docetaxel","id":"OG001","title":"Chemotherapy Alone"}],"populationDescription":"This study terminated early with 15 subjects out of 240 subjects accrued, therefore no analyses were performed.","reportingStatus":"POSTED","timeFrame":"Date of death or last follow-up","title":"Overall Survival","type":"PRIMARY"}